Case Study
AI-Powered Synchronized HCP & DTC Engagement Drives Significant Treatment Adoption in Rare Neurology
Client
Treatment Adoption in Rare Neurology
Key Results
16.3x higher likelihood of treatment adoption among synchronized HCP + DTC audiences
The challenge
Reaching Rare Disease Patients Before Critical Treatment Decisions
For patients living with generalized myasthenia gravis (gMG), treatment decisions often occur at pivotal moments when symptoms worsen and escalation beyond first-line therapy becomes necessary. The challenge was identifying eligible patients before those decisions occurred and ensuring both patients and healthcare providers had access to relevant information ahead of treatment discussions. Traditional marketing approaches often treat provider engagement and patient outreach as separate initiatives, limiting opportunities to influence care decisions through coordinated communication.
The solution
Predictive Patient Identification
AI and predictive analytics were used to identify uncontrolled gMG patients most likely to require advanced therapy and map the providers involved in their care.
Coordinated HCP and Patient Engagement
Providers received EHR-integrated messaging directly within their clinical workflows, while patients were engaged through privacy-safe omnichannel campaigns prior to key appointments and treatment decisions.
Omnichannel AI Orchestration
Campaigns were continuously optimized using dynamic audience updates and activated across preferred channels including EHR, digital, social, CTV/OTT, email, and field-force alignment.
The results
Coordinated Engagement Delivered Stronger Treatment Adoption
While both patient and provider campaigns independently influenced behavior, the greatest impact occurred when the two worked together. The synchronized strategy created meaningful reinforcement between patient awareness and provider engagement, resulting in significantly higher treatment adoption compared to standalone campaigns.
Key results
Higher Treatment Adoption
16.3x
Greater Patient Impact
4x
Greater Provider Impact
2x
Connected to exposed HCPs
618K+
Results that speak for themselves.
From rare disease to mass markets, our clients move faster, waste less, and turn coordinated marketing into measurable script lift.
Data Driven Decision-Making Drove 10:1 Return on TV Ad Spend
Learn how data-driven decision making in pharma delivered a 10:1 ROI on TV ad spend through precise targeting and omnichannel engagement.
The ad ranked in the top 25% for impressions per new prescriptions (NRx) generated.
Return on Advertising Spend (ROAS) Digital Display
Audience segments ranked in the top one-third for impressions per NRx generated.
AI-Powered EHR Messaging Drives Significant Referrals for Rare Disease Treatment Referral
Discover how AI in HCP engagement improved rare disease referrals by delivering timely, EHR-based education to pediatricians and specialists.
Higher Overall Referral Rate in the test group compared to the control group.
Increase in Pediatric Endocrinology Referrals in the test group versus the control group.
Increase in Pediatric Genetics Referrals in the test group
Improving Audience Quality for CTV with Clinical Connected Datasets
See how OptimizeRx drove ROI in pharma CTV advertising by using clinical data and Micro-Neighborhood® targeting to improve audience quality.
OptimizeRx targeting had the best performance of all partners in both audience quality and cost per diagnosed patient
Our Micro-Neighborhood® targeting platform produced higher audience quality than the national benchmark
Higher audience quality rate than the next performing partner
Healthcare marketing is evolving.
Ready for more than just a data vendor?